Summary
This company focuses on developing innovative therapies for individuals suffering from autoimmune diseases. They employ a patient-centered approach to advance treatment options, addressing the complex and variable needs of patients based on disease stage and severity. Their operations include research and development of therapeutic areas, clinical trials, and a commitment to improving the quality of life for patients.
We offer API access to our data.
8 of 8 checks passed
Label
Value
Active Dates
5.5 years — Since Jun 2019
Web Hosting
Platform
E-Mail Provider
Mimecast
NAICS Code
325414
SIC 4 Digit Code
2834
SIC 2 Digit Code
28
Industry
1. Biotechnology and Pharmaceuticals
2. Biological Product (except Diagnostic) Manufacturing
Vendor
Source
Microsoft
TXT Record
Adobe Sign
TXT Record
DocuSign
TXT Record
Smartsheet
TXT Record
Mimecast
TXT Record
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2019 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2020 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2021 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2022 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2023 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2024 |
|
|
|
|
|
|
|
|
|
|
|
|